Research Article
How Important Is the Etiology in the Treatment of Epiphora?
Table 1
Causes of epiphora, duration of complaints, and relationship with gender.
| | Patients (/%) | Duration of complaints (/%) | Sex (%) | value | <1 month | 1 month–1 year | 1–5 years | >5 years |
| (1) Ocular surface disease | 63 (38.7) | 8 (4.9) | 42 (25.7) | 13 (7.9) | | F (57.1) | 0.083 | (a) Dry eye/blepharitis | 63 (38.7) | 8 (4.9%) | 42 (25.7%) | 13 (7.9%) | | F (57.1) | 0.083 |
| (2) Lacrimal pathway diseases | 79 (48.4) | | 32 (19.6) | 42 (25.7) | 6 (3.6) | M (52.5) | 0.663 | (a) Chronic dacryocystitis | 36 (22.1) | | 15 (9.2%) | 15 (9.2%) | 6 (3.6%) | F (69.4) | 0.052 | (b) Congenital lacrimal stenosis | 5 (3.06) | | 5 (3.06%) | | | M (60) | 0.042 | (c) Punctum stenosis | 42 (25.8) | | 13 (7.9%) | 29 (17.7%) | | M (66.6) | 0.233 |
| (3) Eyelid disorders | 35 (21.4) | | 8 (4.9) | 26 (15.9) | 1 (0.6) | M (54.3) | 0.075 | (a) Ectropion | 27 (16.6) | | 5 (3.06%) | 21 (12.8%) | 1 (0.6%) | M (59.2) | 0.151 | (b) Entropion | 5 (3.06) | | 1 (0.6%) | 4 (2.4%) | | M (60) | 0.044 | (c) Trichiasis/distichiasis | 6 (3.6) | | 2 (1.2%) | 4 (2.4%) | | F (50) | 0.083 |
| (4) Others | 4 (2.4) | | 2 (1.2) | 2 (1.2) | | F (50) | 0.083 |
|
|